US Broker Ratings

Vaxcyte, Inc. (PCVX)

⚠️ No article content returned.

..

Bio-Techne Corp (TECH): Stock Analysis Reveals a 17.64% Potential Upside for Investors

Bio-Techne Corporation (NASDAQ: TECH), a prominent player in the biotechnology sector, offers a compelling opportunity for investors seeking exposure to the healthcare industry. With its robust market capitalization of $9.23..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Challenges with a $4.29 Billion Market Cap

Oscar Health, Inc. (NYSE: OSCR) finds itself at a pivotal moment. As a healthcare technology company specializing in offering health plans across various markets, Oscar Health is making significant strides..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: A 24% Upside Potential in the Healthcare Sector

Prestige Consumer Healthcare Inc. (NYSE: PBH) stands out in the healthcare sector with a promising 24.14% potential upside, making it an intriguing option for investors looking to capitalize on the..

Viatris Inc. (VTRS) Stock Analysis: Navigating a 3.90% Dividend Yield Amidst Challenging Metrics

For investors with a keen interest in healthcare stocks, Viatris Inc. (NASDAQ: VTRS) presents a compelling case study. This global healthcare company, with a market capitalization of $14.22 billion, operates..

Chemed Corp (CHE) Stock Analysis: Attractive 32.87% Upside Potential for Savvy Investors

Chemed Corp (NYSE: CHE), a heavyweight in the healthcare sector with a market cap of $6.3 billion, is catching the eye of investors seeking robust growth potential. Trading at $432.18,..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Potential 43.92% Upside in Biotech Growth

TG Therapeutics, Inc. (NASDAQ: TGTX), a prominent player in the biopharmaceutical sector, stands out in the biotechnology industry with a focus on innovative treatments for B-cell mediated diseases. Based in..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring a 138% Potential Upside in the Biotech Arena

Investors with an eye for opportunity in the healthcare sector might find Soleno Therapeutics, Inc. (NASDAQ: SLNO) an intriguing prospect. This clinical-stage biopharmaceutical company, with a market capitalization of $2.56..

Bausch + Lomb (BLCO): Investor Outlook on a Visionary Healthcare Player with a Focused Growth Trajectory

Bausch + Lomb Corporation (BLCO), headquartered in Vaughan, Canada, stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization..

Rhythm Pharmaceuticals (RYTM) Stock Analysis: Exploring a 26% Upside Potential in Biotech

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is a key player in the biopharmaceutical sector, focusing on rare neuroendocrine diseases. With a market capitalization of $7.34 billion, this Boston-based company is an..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: Eyeing a 23.78% Potential Upside with Robust Revenue Growth

iRhythm Technologies, Inc. (NASDAQ: IRTC) is capturing the attention of investors in the healthcare sector, specifically within the medical devices industry. With its significant market cap of $5.69 billion, iRhythm..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring an 8.48% Potential Upside Amid Market Fluctuations

Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector, is attracting investor attention with a potential upside of 8.48%, as indicated by its average target price. The..

Incyte Corporation (INCY) Stock Analysis: Evaluating Growth Potential Amid Strong Revenue Growth and Strategic Collaborations

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, stands out with its robust pipeline and expansive revenue growth, capturing the attention of investors looking for promising opportunities..

BrightSpring Health Services (BTSG) Stock Analysis: Analyst Consensus and Growth Prospects

BrightSpring Health Services, Inc. (NASDAQ: BTSG) is making waves in the healthcare sector, specifically within the health information services industry. With a substantial market cap of $6.81 billion, the company..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Unveiling Challenges and Opportunities in the Biotech Sector

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a leading name in the biopharmaceutical realm, is renowned for its pioneering work in RNA-targeted therapies and gene therapies for rare diseases like Duchenne muscular..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unraveling the 14.19% Potential Upside Amidst Groundbreaking Revenue Growth

BridgeBio Pharma, Inc. (NASDAQ: BBIO), a trailblazer in the biotechnology sector, is capturing investor attention with its remarkable financial and operational metrics. With a market capitalization of $14.61 billion, this..

Elanco Animal Health (ELAN) Stock Analysis: A 10.62% Potential Upside Awaits Investors

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a prominent player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Greenfield, Indiana, Elanco is..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Navigating a 434% Revenue Surge and Potential 3.47% Upside

Avidity Biosciences, Inc. (NASDAQ: RNA), a cutting-edge biopharmaceutical firm, is stirring interest in the biotechnology sector with its innovative approach to RNA therapeutics. With a market capitalization of $10.87 billion,..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: Navigating Through a Promising Biotech Landscape

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, has been turning heads with its promising strides in developing therapeutics for metabolic dysfunction-associated steatohepatitis (MASH). With a..

Option Care Health, Inc. (OPCH) Stock Analysis: A Promising 11.89% Upside in the Healthcare Sector

For investors eyeing opportunities in the healthcare sector, Option Care Health, Inc. (NASDAQ: OPCH) presents a compelling case with its robust growth potential and strong market position. This medical care..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds